News

Actavis’ Lo Loestrin Fe birth control patent protected through 2029

BY Michael Johnsen

DUBLIN — Actavis on Thursday confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid and infringed by Lupin Pharmaceuticals and Amneal Pharmaceuticals' abbreviated new drug applications for generic versions of Actavis' Lo Loestrin Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets).  
 
Lo Loestrin Fe is a prescription birth control pill used for the prevention of pregnancy.  
 
As a result of the Court's ruling, Lupin and Amneal are prevented from launching their generic versions of Lo Loestrin Fe until after the '984 Patent expires on Feb. 2, 2029.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

PhRMA names VP communications

BY Michael Johnsen

WASHINGTON — The Pharmaceutical Research and Manufacturers of America earlier this week announced that Christina Stow will join the organization as VP communications, effective Oct. 27. 
 
Stow will play a key leadership role within the communications department, PhRMA noted. She will oversee a team responsible for the day-to-day activities associated with media relations, including message development, proactive media outreach, rapid response, message research and relationship-building with key reporters and influencers. Stow will report to Robert Zirkelbach, SVP communications.
 
“We are very excited that Tina is joining our communications team here at PhRMA. Her experience managing high-profile public affairs campaigns and her deep knowledge of health care issues will be invaluable to our efforts as we seek to highlight the value of biopharmaceutical innovation and improve patients’ access to medicines,” Zirkelbach said.
 
Stow comes to PhRMA from APCO Worldwide, where she was co-practice Lead of the firm’s corporate communications and issues management service group where she most recently helped design and execute communications strategies for organizations navigating the ongoing implementation of the Affordable Care Act.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

New Boots No7 anti-aging serums to hit retail shelves in November

BY Antoinette Alexander

NEW YORK — Seven years ago, Boots’ anti-aging serums ignited a cult following — the original No7 Protect and Perfect and Protect and Perfect Intense Serums. Now, Boots is unveiling two new No7 serum formulas that promise to hold even greater anti-aging benefits.

Enter No7 Protect and Perfect Advanced and No7 Protect and Perfect Intense Advanced Serums. According to Boots, these serums have been incredibly successful in the United Kingdom with one sold every eight seconds. In the United States, the serums are expected to make waves of their own when they hit shelves beginning in November. The products are available online now.

The new serums are powered by Matrixyl3000 Plus, a combination of the most powerful form of Matrixyl and a next generation peptide, working together for more youthful looking skin, the company stated.

In clinical studies, the new serums were put to the test — not against a placebo, but against the original No7 Protect and Perfect Serums. The results of this double-blind, controlled trial proved that the new No7 Protect and Perfect Advanced Serums were even more effective at reducing the appearance of lines and wrinkles, the company stated.

In consumer studies, designed to show how well the products actually work, 80% of participants saw their best anti-aging results ever. More than 8-out-of-10 women in the user studies preferred the new No7 Protect and Perfect Advanced Serums to their current regimen.

No7 Protect and Perfect Advanced Serum ($22.99 for 30ml) and No7 Protect and Perfect Intense Advanced Serum ($29.99 for 30ml) from Boots will be available at Target stores nationwide, select Walgreens and Duane Reade locations and Ulta starting November. They are available online now at Target.com, Walgreens.com, Drugstore.com, Beauty.com, Ulta.com and us.Boots.com.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?